Want to join the conversation?
$ADSK 1Q15 10-Q: R&D expenses were $194.5MM vs. $170.5MM in 1Q14. Weighted average diluted shares were 231.7MM vs. 231.6MM in 1Q14. At 1Q15-end, 13.2MM shares remained available for repurchase under the repurchase program. Effective tax rate was 12% vs. 21% in 1Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?